Skip to main content

Table 1 Patient demographics of groups E and Ca

From: Pain management after ambulatory surgery: a prospective, multicenter, randomized, double-blinded parallel controlled trial comparing nalbuphine and tramadol

 

Group E

Group C

P

Subjects, n

209

228

 

Gender, n (%)

 Male

52 (25.0)

48 (21.1)

0.340

 Female

156 (75.0)

179 (78.9)

 

Age, y

40.66 ± 12.04

40.67 ± 11.81

0.994

BMI, kg/m2

23.15 ± 2.84

23.20 ± 2.87

0.847

Respiration, rpm

17.09 ± 1.81

17.04 ± 2.18

0.808

Heart rate, bpm

74.45 ± 8.43

74.48 ± 9.75

0.978

Heart rhythm, n (%)

 Normal

207 (99.0)

225 (99.1)

1.000

 Abnormal

2 (1.0)

2 (0.9)

 

SBP, mmHg

121.63 ± 16.26

122.64 ± 16.01

0.513

DBP, mmHg

74.92 ± 9.48

74.63 ± 8.80

0.738

MAP, mmHg

92.91 ± 11.65

93.17 ± 10.84

0.806

  1. aGroup E was treated with nalbuphine hydrochloride diluted with saline to 1 mg/L. Group C was administered tramadol hydrochloride diluted with saline to 10 mg/L.
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us